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Objective: Primary vein incompetence is one of the most common diseases of the peripheral veins, but its pathogenesis is
unknown. These veins present obvious congenital defects, and examination of gene expression profiles of the incompetent
vein specimens may provide important clues. The aim of this study was to screen for genes affecting the primary vein
incompetence phenotype and test the differential expression of certain genes.
Methods: We compared gene expression profiles of valvular areas from incompetent and normal great saphenous veins at
the saphenofemoral junctions by fluorescent differential display reverse-transcription polymerase chain reaction (FDD
RT-PCR). Differentially expressed complimentary DNAs (cDNAs) were confirmed by Northern blotting and semi-
quantitative RT-PCR. Similarity of the cDNAs sequences to GenBank sequences was determined. Gene expression status
was then determined by Western blot analysis and immunohistochemical techniques.
Results: There were >30 differentially expressed cDNA bands. Sequence analysis revealed that a cDNA fragment
obviously downregulated in incompetent great saphenous vein was a portion of the messenger RNA (mRNA) encoding
desmuslin, a newly discovered intermittent filament protein. Northern blotting and semi-quantitative RT-PCR analysis
revealed a similar mRNA expression profile of the desmuslin gene in other samples. Western blotting and immunohis-
tochemical techniques localized the desmuslin protein mainly in the cytoplasm of venous smooth muscle cells. The
amount of desmuslin was greatly decreased in the smooth muscle cells of incompetent veins.
Conclusions: The expression of many genes is altered in primary vein incompetence. Up- or downregulation of these genes
may be involved in the pathogenesis of this disease. Desmuslin expression is downregulated in the abnormal veins. Its
effect on the integrity of smoothmuscle cells might be related tomalformation of the vein wall. Further studies are needed
to investigate other differentially expressed cDNAs and the exact role of desmuslin in this disease.
Clinical Relevance: Primary vein incompetence is a frequent and refractory disease of the peripheral veins. Exploring its
pathogenesis may enhance our comprehension and management of this disease. We used reliable techniques to detect
disease-related genes and confirmed downregulation of desmuslin in abnormal veins. Alteration of these genes might be
used as disease markers or gene therapy targets. ( J Vasc Surg 2006;43:372-8.)Kistner1 first described primary vein incompetence in
1980. It is a frequent disease of peripheral veins and the
most common cause of chronic venous insufficiency, ulti-
mately results in refractory ulceration, accounts for consid-
erable morbidity, and consumes a large part of health-care
resources. Approximately 60% of patients may exhibit fem-
oral and great saphenous vein incompetence at the same
time. Some hypotheses have been proposed to explain the
mechanism of primary vein incompetence, such as the vein
valve hypothesis and the vascular remodeling hypothesis.2,3
Abnormal cellular and molecular alterations of, for exam-
ple, extracellular matrix, smooth muscle cells, and some
cytokines, were found associated with malformation of the
incompetent veins in many studies.4-8
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372By epidemiologic research, Carpentier and Priollet9
noticed a genetic predisposition in some patients that indi-
cated these patients might have had hereditary defects
before they presented with venous malformation. Travers
et al10 also regarded heredity as an important factor for
more than half of the patients with a positive family history,
suggesting a congenital weakness of the vein wall.
In this study, we used the fluorescent differential dis-
play reverse-transcription polymerase chain reaction tech-
nique (FDD RT-PCR) to look for genes involved in the
pathogenesis of primary vein incompetence.
MATERIALS AND METHODS
Patient selection and sample preparation. Twelve
patients who had normal vein valves but presented reflux in
both the femoral and great saphenous vein, diagnosed by
duplex sonography scanning and descending venography,
were recruited to the patient group. None had a history of
venous thrombosis. According to the CEAP classification,
the patients were classified as C2-4EPAS,DPR. An additional
nine patients who were going to receive coronary bypass
and had neither femoral vein nor great saphenous vein
reflux diagnosed by duplex sonography scanning were re-
cruited to the control group. The first valvular areas of the
great saphenous veins (away from the common femoral
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tomy or coronary bypass. Each sample was divided into two
segments—one for histologic study, and the other was
immediately frozen and conserved in liquid nitrogen.
Differential display and complimentary DNA
retrieval. Total RNA was extracted in Trizol reagent
(Gibco BRL, Gaithersburg, Md) following the manufac-
turer’s instructions and further treated with RNase-free
DNase I (Promega BRL,Madison, Wis) to remove residual
genomic DNA. A260/A280 of the total RNA samples
varied from 1.9 to 2.0. Concentrations of all the RNA
samples were adjusted to 1.0 g/L.
Using a series of 2-base-anchored oligo(dT12) primers
(the Genomyx HIEROGLYPH mRNA Profile Kit and
Genomyx HIEROGLYPH DD Kit, Genomyx Corpora-
tion, Foster City, Calif), we subdivided themessenger RNA
(mRNA) population and synthesized the complimentary
DNAs (cDNAs). Four anchored primers and three ran-
domized primers were used (Table I).
After mixing 2.0L of total RNA (1.0g/L) and 2.0
L anchored primer (50 M) and heating the mixture at
70°C for 5 minutes, 2.0 L of 2’-deoxyribonucleoside
5’-triphosphate (dNTP) (200 M, 1:1:1:1), 2.0 L of
dithiothreitol (DTT) (10 mM), 4.0 L of 5 SuperScript
II RT buffer, 0.1 of L SuperScript II RT (20 U/L), and
7.1 of L distilled water were added. The mixture was
incubated at 42°C for 10 minutes, at 50°C for 60 minutes,
and at 70°C for 15 minutes.
The PCR system included 2.0 L of cDNAs, 0.7 L of
the relevant anchored primer (5 M), 1.75 L of random-
ized primers (2 M), 2.0 L of dNTP (200 M, 1:1:1:1),
1.5L ofmagnesium chloride (25mM), 1L of 10 PCR
buffer, 0.25 L of AmpliTaq DNA polymerase (5 U/L),
and 0.8L of distilled water. Lightmineral oil was overlaid.
After denaturation at 94°C for 5min, PCR reaction was
carried out for four cycles at 94°C for 30 seconds, 50°C for
40 seconds, and 72°C for 2 minutes, followed by 30 cycles
at 94°C for 30 seconds, 55°C for 40 seconds, and 72°C for
2 minutes. PCR products then were separated on 6% DNA
Table I. Sequences of primers used in fluorescent
differential display*
Anchored primers
TMR-T7(dT12)AP1-
5=ACGACTCACTATAGGGCTTTTTTTTTTTTGA3=,
TMR-T7(dT12)AP2-
5=ACGACTCACTATAGGGCTTTTTTTTTTTTGC3=
TMR-T7(dT12)AP3-
5=ACGACTCACTATAGGGCTTTTTTTTTTTTGG3=
TMR-T7(dT12)AP4-
5=ACGACTCACTATAGGGCTTTTTTTTTTTTGT3=
Randomized primers
M13r-ARP18-5’
ACAATTTCACACAGGATGATGCTACC3=,
M13r-ARP19-5’
ACAATTTCACACAGGATTTTGGCTCC3=,
M13r-ARP20-5’ ACAATTTCACACAGGATCGATACAGG3=
*The italic sequences are primer T7 and M13sequencing gel containing 7M urea. The gel was driedwithout fixing and screened in a GenomyxSC scanner
(Beckman-Coulter, Fullerton, Calif).
Differentially expressed cDNAs were identified by Im-
age Quant software (Molecular Dynamics, Sunnyvale,
Calif). Corresponding gel bands were excised from the
dried gel. Each gel slice was and incubated in 50 L of
distilled water, then boiled for 15 minutes to release the
cDNAs. The cDNAs were precipitated by ethanol in the
presence of 0.3M sodium acetate and 2.5L of 10mg/mL
glycogen, redissolved in 20 L of distilled water, and then
reamplified under PCR conditions as used in differential
display; the anchored and randomized primers were re-
placed by T7 and M13 universal primers. PCR products
were purified using Qiagen PCR Purification Kit (Hilden,
Germany).
Northern blotting confirmation. A portion of the
purified cDNAs were labeled with [-32P]2’-deoxycyti-
dine-5’-triphosphate (dCTP) to prepare probes according
to the manufacturer’s instructions. Thirty micrograms of
total RNA of each sample, which had been used in differ-
ential display experiments, was electrophoresed on 1.5%
agarose gel containing 6% formaldehyde and 1 morpho-
linopropanesulfonate (MOPS) buffer (20 mM of MOPS, 5
mM of sodium acetate, and 1 mM of ethylenediaminetet-
raacetic acid).
The RNAs were then transferred to a nylon membrane
in 10 standard saline citrate (SSC) buffer and incubated at
80°C for 2 hours to crosslink the RNA and the membrane.
cDNA probes then hybridized to the mRNAs on the mem-
branes in buffer containing 50% formamide, 5 SSC, 5
Bernhardt’s solution, 0.5% sodium dodecylsulfate (SDS),
10% dextran sulfate, and 100 g/mL denatured salmon
sperm at 50°C for 20 hours in a rotating hybridization oven
(Tyler HI-16000, Edmonton, Alberta, Canada). After hy-
bridization, the membranes were washed twice with 2
SSC and 0.1% SDS for 10 minutes, and twice with 0.1
SSC and 0.1% SDS for 30 minutes at room temperature.
The hybridization signals were visualized with chemi-
luminescence and recorded on x-ray film. The exposure
time was 30 minutes. Hybridization signals were analyzed
with a PhosphorImager scanning system (Molecular Dy-
namics/Amersham Biosciences/Amersham, Piscataway,
NJ) and ImageQuant software (Molecular Dynamics,
Sunnyvale, Calif).
Cloning and sequencing of differentially expressed
cDNAs. Reamplified cDNAs were cloned into pGEM-
Teasy vector (Promega BRL, Madison, Wis) after QiaexII
gel (Qiagen) purification and transferred to Escherichia coli
DH5. After ampicillin selection and proliferation, the
plasmids were extracted and digested by EcoRI enzyme.
Positive clones were sequenced using SP6 primer. cDNA
sequences were analyzed for matches in the GenBank da-
tabase via the BLAST program.
Semi-quantitative RT-PCR. To identify whether the
differentially expressed cDNA that matched desmuslin
mRNA in sequence presented the same expression profile
in other vein samples, semi-quantitative RT-PCR was done
with specific primers. The human -actin gene was used for
GGG
JOURNAL OF VASCULAR SURGERY
February 2006374 Yin et althe intrinsic reference. The sequences of these primers are
listed in Table II.
Total RNA isolation was by the same procedure as
previously described. Reverse transcriptions were per-
formed by using oligo(dT17) nucleotide. Exactly 2.0 L of
total RNA (1.0 g/L) and 1.0 L of oligo(dT) primer
(0.5 g/L) were incubated together at 70°C for 5 min-
utes. Then 2.0 L of dNTP (200 M, 1:1:1:1), 2.0 L of
DTT (10mM), 4.0 L of 5 SuperScript II RT buffer, 0.1
L of SuperScript II reverse transcriptase (20 U/L), and
8.9 L of distilled water were added. The mixture was
incubated at 37°C for 1 hour. The PCR system included
1.0 L of cDNAs, 0.2 L of sense and antisense -actin
primers, 4.0 L of dNTP (200 M, 1:1:1:1), 4.0 L of
magnesium chloride (25 mM), 5.0 L of 10 PCR buffer,
0.25 L of AmpliTaq DNA polymerase (5U/L), and
33.35 L of distilled water. Light mineral oil was overlaid.
After the PCR reaction was done for 20 cycles at 94°C
for 30 seconds, 50°C for 40 seconds, and 72°C for 2
minutes, 1.0L of specific sense and antisense primers were
added, and the reaction went on for 25more cycles at 94°C
Fig 1. mRNA differential display (with primer pair AP3 and
ARP18). P1, P2, N1, N2, and M represent two incompetent veins,
two normal veins, and DNA marker, respectively. The P24 cDNA
fragment is marked with the black arrow on the left.
Table II. Primer sequences used in semi-quantitative reve
-actin forward 5=-GTGG
reverse 5=-CTTCC
Desmuslin sense 5=-CTTGG
Antisense 5=-AACCAfor 30 seconds, 52°C for 40 seconds, and 72°C for 2minutes. PCR products were then electrophoresed on 1.0%
agarose gel and analyzed by using ImageQuant software.
Western blotting analysis. Equal amounts of vein
samples from the two groups were homogenized in lysis
buffer (20 mM of 4-[2-hydroxyethyl]-1-piperazineethane-
sulfonic acid [HEPES], pH 7.2; 1% Triton X-100, 1%
deoxycholate, 0.1% SDS, 150 mM of sodium chloride, 10
g/mL of leupeptin, 10g/mL of aprotinin, and 1 of mM
phenylmethylsulfonyl fluoride) and centrifuged. The su-
pernatants were separated on 8% SDS polyacrylamide gel
electrophoresis and blotted onto a nitrocellulose transfer
membrane (Schleicher & Schuell Bioscience, Keene, NH).
Themembranes were probed with antidesmuslin monoclo-
nal antibody (kindly provided by Yuji Mizuno) diluted
1:1000 in blocking solution.
The reaction was visualized by labeling with goat anti-
rabbit immunoglobulin G secondary antibody (Sengon,
Shanghai, China). The peroxidase reaction was developed
with Amersham ECL reagents (Amersham Biosciences).
After imaging, the membranes were stripped and reprobed
by using monoclonal anti--actin peroxidase antibody as
the primary antibody (Sigma, St. Louis, Mo).
Immunohistochemical study. Paraffin-embedded
vein tissues were cut into 5 m sections, deparaffinized in
xylene, and rehydrated through a series of alcohol and
water. The slides were placed in 10 mmol/L citrate buffer
(pH 6.0) and microwaved for 15 minutes to enhance
antigen exposure. The sections were first incubated in
hydrogen peroxide (30 mL/L) for 10 minutes to quench
endogenous peroxidase activity and then washed in phos-
phate-buffered saline (PBS) (pH 7.6). They were incubated
with PBS containing normal goat serum for 30 minutes,
followed by incubation with primary rabbit antihuman
desmuslin antibody (1:200 dilution) for 30 minutes at
37°C. Sections were then incubated with goat anti-rabbit
secondary antibody for 30 minutes before they were re-
acted with diaminobenzidine solution. On the basis of the
intensity and the number of cells stained, expression of
desmuslin was defined as moderate-to-strong staining af-
fecting more than 30% of the slice.
Statistical analysis. The results were expressed as
mean  SD. The significance was determined by the t test
or nonparametric test; P.05 was considered statistically
significant. All analyses were performed using SPSS 13.0
software (SPSS, Inc, Chicago, Ill).
RESULTS
Messenger RNA differential display. Screening the
ranscription polymerase chain reaction analysis
Sequence Product length
GCCCCAGGCACCA-3= 500 bp
ATGTCACGCACGATTTC-3=
GATGAAATAG-3= 300 bp
TCACGGAACT-3=rse-t
GGC
TTA
CAGmRNA profile under primer AP3 and ARP18 revealed an
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weaker in incompetent veins, as shown in Fig 1. The cDNA
was named P24.
Northern blotting. Differential expression of P24
cDNA was confirmed by Northern blotting analysis (Fig 2,
A), which indicated that expression of the corresponding
mRNA was at a very low level in the incompetent veins. Fig
2, B shows the abundance of 18S and 28S rRNA. The
relative signal intensities (Fig 2, A)compared with those of
the corresponding 28S rRNAs (Fig 2, B)were submitted to
a t test; patient group, 0.06 0.016 vs control group, 0.24
 0.039 (P .001, 95% confidence interval [CI], 0.1478,
0.2089).
Sequence analysis. The nucleotide sequence analysis
revealed that the P24 fragment consisted of 585 bases. As
shown in Fig 3, the oblique bold bases near the 5= and 3=
ends were the M13 and T7 universal primers. Comparison
with GenBank database sequences via the BLAST program
revealed that P24 cDNA was a portion of the desmuslin
mRNA.
Semi-quantitative RT-PCR. Results indicated that
downregulation of desmuslin was also present in other
patients with primary vein incompetence. This result
agreed with those of the mRNA differential display and
Northern blotting. The average relative integrated optical
Fig 2. Northern blotting confirmation of differential ex
and two normal veins, respectively. A, Shows that the exp
than in the normal veins (normalized to the expression o
consistent with the result of differential display.
5 -TCCCATATGGTCGACCTGCAGGCGGCCGCGAATTCACTAGTGATT  ACAATTTCACACAGGA  
GATCTCAGACGGGCACATCTATTGGAGGTGATGCCAGAAGAGGCTTCTTGGGCTCGGGATATTCTTC 
CTCGGCCACTACCCAGCAGGAAAACTCATACGGAAAAGCCGTCAGCAGTCAAACCAACGTCAGAAC 
TTTCTCTCCAACCTATGGCCTTTTAAGAAATACTGAGGCTCAAGTGAAAACATTCCCTGACAGACCAA 
AAGCCGGAGATACAAGGGAGGTCCCCGTTTACATAGGTGAAGATTCCACAATTGCCCGCGAGTCGTA 
CCGGGATCGCCGAGACAAGGTGGCAGCAGGTGCTTCGGAAAGCACACGGTCAAATGAGAGGACCGT 
CATTCTGGGAAAGAAAACAGAAGTGAAAGCCACGAGGGAGCAAGAAAGAAACAGACCAGAAACCA 
TCCGAACAAAGCCAGAAGAGAAAATGTTCGATTCTAAAGAGAAGGCTTCCGAGGAGAGAAACCTAA 
GATGGGAAGAATTGACAAAGTTAGAAAAAAAAA   GCCCTATAGTGAGTCGT   AATCGAATT- 3 
M 13  primer  
T 7  primer  
Fig 3. Sequence of P24 cDNA. T7 and M13 universal primers at
the two ends are indicated by arrows.density values of desmuslin bands, normalized to the valueof the corresponding -actin (patient group, 0.19 0.047;
control group, 0.83 0.082), were submitted to a t test (P
.001, 95% CI, 0.576, 0.710) (Fig 4).
Western blotting analysis. Desmuslin levels were sig-
nificantly lower in the incompetent veins than the normal
veins (the intensity of each desmuslin band was normalized
to that of the corresponding -actin band). Average inten-
sities of the bands for the patient (0.25  0.062) and
control (1.03 0.130) groups were submitted to a t test (P
.001, 95% CI, 0.687, 0.868) (Fig 5).
Immunohistochemical study. Moderate-to-strong
expression of desmuslin was observed in 83.7%  6.2%
smooth muscle cells of normal vein specimens, whereas
only 21.2%  8.3% smooth muscle cells in incompetent
veins presented a weak-to-moderate expression. The data
were submitted to nonparametric test, Z  3.202, P
.001. Desmuslin was localized in the cytoplasm of venous
smooth muscle cells (Fig 6).
DISCUSSION
Using the FDD RT-PCR technique11,12 in the present
study, we discovered quite a few differentially expressed
genes related with primary vein incompetence. The pres-
ence of differentially expressed cDNAs suggests that the
expression of many genes is changed in response to the
pathophysiologic circumstances of primary vein incompe-
tence. Whether these differentially expressed genes are
involved in the pathogenesis of this disease remains to be
investigated.
In this study, we confirmed downregulation of the
desmuslin gene in the incompetent vein walls. The desmus-
lin gene, located on chromosome 15q26.3,13 encodes a
newly discovered protein belonging to the intermediate
filament protein (IF) family.14 Sequence analysis suggests
that desmuslin contains an IF signature, indicating that
desmuslin may be a structural protein.15 Of the various IF
proteins, desmuslin is most similar to synemin, paranemin,
tanabin, and nestin in terms of domain structure.16-19
Desmuslin is classified as a type 6 IF protein. There are at
on of P24. P1, P2, andN1,N2 represent two incompetent
n of P24 cDNA is much weaker in the incompetent veins
corresponding 28S rRNA as shown in B). This result ispressi
ressio
f theleast two distinct desmuslin subpopulations, one that inter-
other
rol gr
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other that interacts with both dystrobrevin and desmin at
the costamere.
IF proteins such as desmuslin and desmin are thought
to help maintain the structural integrity of tissues by me-
chanically reinforcing protein connections. Desmin encir-
cles Z-lines and then makes longitudinal filamentous
bridges between neighboring Z-lines. These bridges are
supported by plectin and crystallin.20 Plectin links desmin
to the Z-discs and desmin to itself.21
Mutations in the desmin gene can cause desmin myop-
athies characterized by muscle weakness, cardiac impair-
ment, and intracytoplasmic accumulation of desmin depos-
its.22-25 Desmuslin forms a linkage between a component
of dystrophin-associated protein complex (-dystrobrevin)
and a component of the Z-lines (desmin), thus connecting
the extracellular matrix to the Z-discs. Laminin, the extra-
Fig 4. Semi-quantitative reverse-transcriptase polymera
veins.N and P represent the normal and incompetent vein
that expression of desmuslin was also downregulated in
Fig 5. Western blotting analysis of desmuslin expressio
expression. B, shows -actin expression.N and P represe
were much weaker in the patient group than in the contcellular matrix protein laminin that interacts with -dystro-glycan, can extend this linkage to the extracellular matrix.26
Disruption of any of the proteins in this linkage could
potentially damage muscle cell integrity. We discovered
that desmuslin expressed in venous smooth muscle cells is
greatly downregulated. This decline in desmuslin may dis-
turb the integrity of venous smooth muscle cells.
Many studies have confirmed that smooth muscle cells
are important for the maintenance of venous tone. The
“weak wall with secondary valvular incompetence” theory
has been proposed as the most likely cause of primary vein
incompetence.27 Venturi et al28 considered the primary
defect could be in the smooth muscle cells of the vein wall,
which are responsible for the synthesis and catabolism of
both collagen and elastin. Rose and Ahmed29 suggested
that separation of muscle cells by fibrous infiltration pre-
vented them from acting as a unified whole, with subse-
quent alterations in wall tone leading to pathologic dilata-
in reaction analysis of desmuslin mRNA in incompetent
pectively;M is the100-bpDNA ladder. The figure shows
patients.
file in normal and abnormal veins. A, Shows desmuslin
rmal and abnormal veins, respectively. Desmuslin signals
oup.se cha
s, resn pro
nt notion. Wali and Eid30 found that the smooth muscle fibers
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peared completely in incompetent vein wall. Disorganized
muscular structure invaginated and separated into the lay-
ers containing increased amounts of collagen.
The separation and disruption of muscle cell fibers may
cause diminished tone and vein wall dilatation, as “effective
contraction cannot occur unless individual cells are in com-
munication with each other.”30 Relaxation of the muscle
cells, gradual decay of the muscle cells, and decreased
tensile strength and elasticity of the connective tissue fibers
are direct reasons for the dilatation and lateral blowouts of
veins.31 Taken together, these and our results suggest that
the downregulation of desmuslin in the vein wall may be
responsible for smoothmuscle cell change and for weakness
and dilatation of the vein wall.
CONCLUSION
We propose that downregulation of desmuslin, proba-
bly together with defects or deficits in other structural
proteins, may result in venous smooth muscle cell malfor-
mation, which in turn, contributes to the dilatation of the
vein wall and secondary valve incompetence. So far, we
Fig 6. Immunohistochemical analysis of desmuslin in vein walls.
A, Specimen of normal vein (200magnification); B, Specimen of
incompetent vein (200 magnification). Signals are abundant and
intense in smooth muscle cell cytoplasm of normal veins but
infrequent and weak in incompetent veins (as shown by black
arrows).have no certain proof what the initial accident is, how theserelative molecules interact with each other, and how they
influence the function of the vein. The mechanism needs
further investigation.
We sincerely thank Prof. Yuji Mizuno for his kindly
provision of desmuslin antibody.
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